Neogen (NEOG) Cost of Revenue (2010 - 2026)
Neogen's (NEOG) quarterly Cost of Revenue came in at $112.2 million in Q1 2026, up 1.36% year-on-year from $110.7 million in Q1 2025, and down 4.92% quarter-over-quarter from $118.0 million in Q4 2025.
Neogen (NEOG) Cost of Revenue (2010 - 2026) Analysis & Trends
Neogen's Cost of Revenue history runs 17 years deep, the most recent figure standing at $112.2 million for Q1 2026.
- On a quarterly basis, Cost of Revenue rose 1.36% year-over-year to $112.2 million in Q1 2026; TTM through Feb 2026 was $477.0 million, a 2.81% increase from a year earlier, with the FY2025 full-year figure at $473.3 million, up 2.82% from the prior year.
- Cost of Revenue fell to $112.2 million in Q1 2026 per NEOG's latest filing, from $118.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $132.6 million in Q2 2025 and bottomed at $70.1 million in Q3 2022.
- The 5-year median for Cost of Revenue is $112.2 million (2023), against an average of $108.3 million.
- Across the five-year window, Cost of Revenue soared 68.03% in 2022 and fell 3.95% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $117.5 million in 2022, then decreased by 3.95% to $112.9 million in 2023, then advanced by 4.5% to $117.9 million in 2024, then increased by 0.07% to $118.0 million in 2025, then slipped by 4.92% to $112.2 million in 2026.
- Per Business Quant, the three latest NEOG Cost of Revenue figures stand at $112.2 million (Q1 2026), $118.0 million (Q4 2025), and $114.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 112.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 112.20 Mn |
| Feb 28, 2026 | 112.20 Mn |
| Nov 30, 2025 | 118.01 Mn |
| Nov 30, 2025 | 118.01 Mn |
| Aug 31, 2025 | 114.22 Mn |
| Aug 31, 2025 | 114.22 Mn |
| May 31, 2025 | 132.59 Mn |
| May 31, 2025 | 132.59 Mn |
| Feb 28, 2025 | 110.70 Mn |
| Feb 28, 2025 | 110.70 Mn |
| Nov 30, 2024 | 117.93 Mn |
| Nov 30, 2024 | 117.93 Mn |
| Aug 31, 2024 | 112.04 Mn |
| Aug 31, 2024 | 112.04 Mn |
| May 31, 2024 | 123.31 Mn |
| May 31, 2024 | 123.31 Mn |
| Feb 29, 2024 | 111.93 Mn |
| Feb 29, 2024 | 111.93 Mn |
| Nov 30, 2023 | 112.86 Mn |
| Nov 30, 2023 | 112.86 Mn |